Top

Published in:

01-02-2019 | Case Report

Recurrent strokes, central nervous system vasculitis, and acquired protein S deficiency secondary to varicella zoster in a child with AIDS

Authors: Jake A. Deviley, Darby Oldenburg, Laurence C. Berg, William A. Agger

Published in: Journal of NeuroVirology | Issue 1/2019

Abstract

A child with vertical transmission of human immunodeficiency virus refractory to therapy developed zoster-induced protein S deficiency and recurrent strokes. Extensive carotid arteritis was found postmortem. The carotid tissue was positive for herpes varicella zoster by polymerase chain reaction, as were immunofixation stains of the arterial wall.

Benjamin LA, Bryer A, Emsley HC, Khoo S, Solomon T, Connor MD (2012) HIV infection and stroke: current perspectives and future directions. Lancet Neurol 11:878–890. https://doi.org/10.1016/S1474-4422(12)70205-3 CrossRefPubMedPubMedCentral

Fair DS, Marlar RA, Levin EG (1986) Human endothelial cells synthesize protein S. Blood 67:1168–1171PubMed

Ferrara M, Bertocco F, Ferrara D, Copozzi L (2013) Thrombophilia and varicella zoster in children. Hematology 18:119–122. https://doi.org/10.1179/1607845412Y.0000000055 CrossRefPubMed

Gilden DH, Kleinschmidt-DeMasters BK, Wellish M, Hedley-Whyte ET, Rentier B, Mahalingam R (1996) Varicella zoster virus, a cause of waxing and waning vasculitis: The New England Journal of Medicine case 5-1995 revisited. Neurology 47:1441–1446. https://doi.org/10.1212/WNL.47.6.1441 CrossRefPubMed

Gutierrez J, Ortiz G (2011) HIV/AIDS patients with HIV vasculopathy and VZV vasculitis. Clin Neuroradiol 21:145–151. https://doi.org/10.1007/s00062-011-0087-0 CrossRefPubMed

Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Straus SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, Simberkoff MS, Weinberg A, Williams HM, Cheney C, Petrukhin L, Abraham KG, Shaw A, Manoff S, Antonello JM, Green T, Wang Y, Tan C, Keller PM, Shingles Prevention Study Group (2009) A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol 81:1310–1322. https://doi.org/10.1002/jmv.21506 CrossRefPubMedPubMedCentral

Josephson C, Nuss R, Jacobson L, Hacker MR, Murphy J, Weinberg A, Manco-Johnson MJ (2001) The varicella-autoantibody syndrome. Pediatr Res 50:345–352. https://doi.org/10.1203/00006450-200109000-00009 CrossRefPubMed

Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, Weinberg A, Lefkowitz J (1996) Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 128:319–323CrossRefPubMed

Nagel MA, Gilden D (2014) Update on varicella zoster virus vasculopathy. Curr Infect Dis Rep 16:407. https://doi.org/10.1007/s11908-014-0407-z CrossRefPubMedPubMedCentral

Nagel M, Gilden D (2016) Developments in varicella zoster virus vasculopathy. Curr Neurol Neurosci Rep 16:1–8. https://doi.org/10.1007/s11910-015-0614-5 CrossRef

Nagel MA, Mahalingam R, Cohrs RJ, Gilden D (2010) Virus vasculopathy and stroke: an under-recognized cause and treatment target. Infect Disord Drug Targets 10:105–111CrossRefPubMedPubMedCentral

Nagel MA, Lenggenhager D, White T, Khmeleva N, Heintzman A, Bover PJ, Gilden D (2015) Disseminated VZV infection and asymptomatic VZV vasculopathy after steroid abuse. J Clin Virol 66:72–75. https://doi.org/10.1016/j.jcv.2015.03.016 CrossRefPubMedPubMedCentral

Newsome SD, Nath A (2009) Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neuro-Oncol 15:288–291. https://doi.org/10.1080/13550280902913610 CrossRef

Nguyên P, Reynaud J, Pouzol P, Munzer M, Richard O, François P (1994) Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children. Eur J Pediatr 153:646–649CrossRefPubMed

Pinninti S, Hough-Telford C, Pati S, Boppana S (2016) Cytomegalovirus and Epstein-Barr virus infections. Pediatr Rev 37:223–234. https://doi.org/10.1542/pir.2015-0072 CrossRefPubMed

Shafran SD (2016) Live attenuated herpes zoster vaccine for HIV-infected adults. HIV Med 17:305–310. https://doi.org/10.1111/hiv.12311 CrossRefPubMed

Teo SY, Raha D, Warren D, Hassan A, Monteiro E (2014) Central nervous system–immune reconstitution inflammatory syndrome presenting as varicella zoster virus-mediated vasculitis causing stroke. Int J STD AIDS 25:683–685. https://doi.org/10.1177/0956462413518501 CrossRefPubMed

Thomson JJ, Retter A, Hunt BJ (2010) Novel management of post varicella purpura fulminans owing to severe acquired protein S deficiency. Blood Coagul Fibrinolysis 21:598–600. https://doi.org/10.1097/MBC.0b013e32833c2b52 CrossRefPubMed

van der Ven AJAM, van Oostenbrugge RJ, Kubat B, Tervaert JW (2002) Cerebral vasculitis after initiation antiretroviral therapy. AIDS 16:2362–2364CrossRefPubMed

Title: Recurrent strokes, central nervous system vasculitis, and acquired protein S deficiency secondary to varicella zoster in a child with AIDS
Authors: Jake A. Deviley
Darby Oldenburg
Laurence C. Berg
William A. Agger
Publication date: 01-02-2019
Publisher: Springer International Publishing
Published in: Journal of NeuroVirology / Issue 1/2019
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI: https://doi.org/10.1007/s13365-018-0697-2

At a glance: The STEP trials

Springer Medicine

Recurrent strokes, central nervous system vasculitis, and acquired protein S deficiency secondary to varicella zoster in a child with AIDS

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Herpes zoster increased risk of neuralgic amyotrophy: a retrospective, population-based matched cohort study

HERV-W env regulates calcium influx via activating TRPC3 channel together with depressing DISC1 in human neuroblastoma cells

Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir

Vibrio vulnificus meningoencephalitis in a patient with thalassemia and a splenectomy

Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

The bovine herpesvirus 1 regulatory proteins, bICP4 and bICP22, are expressed during the escape from latency